Ignite Creation Date:
2025-12-25 @ 1:10 AM
Ignite Modification Date:
2025-12-27 @ 1:46 AM
Study NCT ID:
NCT06851793
Status:
COMPLETED
Last Update Posted:
2025-12-18
First Post:
2024-10-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Investigating Postural Parameters in Different Hip Pathologies
Sponsor:
Hacettepe University
Organization:
Study Overview
Official Title:
Investigation of Postural Parameters, Physical Functions, Balance and Quality of Life in Different Hip Pathologies
Status:
COMPLETED
Status Verified Date:
2025-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
"It is known that pelvic parameters affect physical hip functions in hip pathologies. Depending on the type and severity of hip pathologies, posture, muscle strength, balance, and pain parameters may change, thereby impacting an individual's quality of life. This study aimed to examine the postural parameters, muscle strength, balance, quality of life, pain intensity, and pain localization of individuals with different hip pathologies, including hip osteoarthritis, hip impingement syndrome, hip labrum tear, hip dysplasia, and hip avascular necrosis."
Detailed Description:
Volunteers with hip pathologies, such as hip osteoarthritis, hip impingement syndrome, hip labrum tear, hip dysplasia, and hip avascular necrosis, will be included in the study. Prior to the study, the responsible researcher will provide detailed face-to-face information regarding the study's content, the scales to be applied, the importance of these scales, and the evaluation processes. Individuals who agree to participate will sign an informed consent form before the evaluations begin. Demographic information will be recorded, and the dominant extremity for both the upper and lower extremities will be determined.
The measurements and evaluations will be conducted by the same researcher using a consistent evaluation method for all participants included in the study.
Volunteers with hip joint pathologies who apply to the Orthopedic Unit of Hacettepe University Faculty of Physical Therapy will be included in the study. During the initial interview, participants will be informed about the surveys and the parameters to be evaluated. The sample size was calculated using the G\*Power 3.1 program, with an effect size of 0.74, an alpha error rate of 0.05, and a test power of 0.80. This included individuals with various hip pathologies (hip osteoarthritis, hip impingement syndrome, hip labrum tear, hip dysplasia, and hip avascular necrosis). The sample size for the study was determined to be 30 individuals with hip pathologies and 30 healthy individuals. To account for potential incomplete evaluations, a total of 66 participants, with an additional 10%, will be included.
Inclusion Criteria:
Diagnosed with one of the following: hip osteoarthritis, hip impingement syndrome, hip labrum tear, hip dysplasia, or hip avascular necrosis, experiencing mechanical impact on the hip joint, symptoms ongoing for at least 6 months, aged between 18 and 65 years
Exclusion Criteria:
Diagnosed with scoliosis by a physician, diagnosed with any developmental disorder (e.g., Scheuermann's/Calve disorder), diagnosed with a neurological and/or cognitive disease that may affect cognitive functions, diagnosed with inflammatory arthritis, underwent surgery on the spine or extremities, diagnosed with an infection (e.g., spinal tuberculosis) or tumor (e.g., multiple myeloma), epilepsy or use of antidepressants/attention-enhancing drugs.
The measurements and evaluations will be conducted by the same researcher using a consistent evaluation method for all participants included in the study.
Volunteers with hip joint pathologies who apply to the Orthopedic Unit of Hacettepe University Faculty of Physical Therapy will be included in the study. During the initial interview, participants will be informed about the surveys and the parameters to be evaluated. The sample size was calculated using the G\*Power 3.1 program, with an effect size of 0.74, an alpha error rate of 0.05, and a test power of 0.80. This included individuals with various hip pathologies (hip osteoarthritis, hip impingement syndrome, hip labrum tear, hip dysplasia, and hip avascular necrosis). The sample size for the study was determined to be 30 individuals with hip pathologies and 30 healthy individuals. To account for potential incomplete evaluations, a total of 66 participants, with an additional 10%, will be included.
Inclusion Criteria:
Diagnosed with one of the following: hip osteoarthritis, hip impingement syndrome, hip labrum tear, hip dysplasia, or hip avascular necrosis, experiencing mechanical impact on the hip joint, symptoms ongoing for at least 6 months, aged between 18 and 65 years
Exclusion Criteria:
Diagnosed with scoliosis by a physician, diagnosed with any developmental disorder (e.g., Scheuermann's/Calve disorder), diagnosed with a neurological and/or cognitive disease that may affect cognitive functions, diagnosed with inflammatory arthritis, underwent surgery on the spine or extremities, diagnosed with an infection (e.g., spinal tuberculosis) or tumor (e.g., multiple myeloma), epilepsy or use of antidepressants/attention-enhancing drugs.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: